Could VEGF-D level have a role in clinical risk scoring, estimation of thrombus burden, and treatment in acute pulmonary thromboembolism?

Bugra Kerget Dursun Erol Afşin Alperen Aksakal Ferhan Kerget Seda Aşkın Elif Yılmazel Uçar Leyla Sağlam

Published in: International journal of clinical practice (2021)

This study showed that plasma VEGF-D level was more reliable than troponin-I and NT-proBNP in clinical risk scoring and demonstrating thrombus burden. VEGF-D can be used as a biomarker in clinical risk scoring and estimation of thrombus burden in patients with acute PE.

Keyphrases

vascular endothelial growth factor
endothelial cells
pulmonary hypertension
risk factors
respiratory failure
aortic dissection
smoking cessation